Loading…
Loading…
EQUITY / NASDAQ · XNCM
Bone Biologics Corp
01 / RESEARCH
8 financial reports are available for research.
Start research ↗0.4963 USD
Observed: 09/30/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
09/30/2026 · 0.4963 USD · Volume 36,522
680 actual observations · Latest bar: 2026-09-30 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Net income | -773,702 USD | -740,519 USD | — |
| Operating profit | -808,106 USD | -748,075 USD | — |
| Total assets | 4,436,668 USD | — | — |
| Total equity | 3,924,650 USD | 6,596,074 USD | -40.50% |
| Total liabilities | 512,018 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2026 / Quarter 2ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD | 2025 / Year endConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 3ConsolidatedUnits · USD | 2025 / Quarter 2ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Net incomeIncome statement | -773,702 USD | -1,539,690 USD | -765,988 USD | — | -3,108,991 USD | -666,737 USD | -2,424,348 USD | -740,519 USD |
| Operating profitIncome statement | -808,106 USD | -1,613,160 USD | — | — | -3,234,942 USD | -715,274 USD | -2,501,837 USD | -748,075 USD |
| Total assetsBalance sheet | 4,436,668 USD | — | — | 5,796,135 USD | 5,796,135 USD | 6,350,799 USD | — | — |
| Total equityBalance sheet | 3,924,650 USD | — | 4,669,919 USD | 5,377,548 USD | 5,377,548 USD | 6,016,517 USD | — | 6,596,074 USD |
| Total liabilitiesBalance sheet | 512,018 USD | — | — | 418,587 USD | 418,587 USD | 334,282 USD | — | — |
| Financing cash flowCash flow statement | — | 20,180 USD | — | — | 4,700,341 USD | — | 4,700,341 USD | — |
| Operating cash flowCash flow statement | — | -1,322,722 USD | — | — | -2,691,150 USD | — | -1,976,388 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/02/2026 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 11/14/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.